Kate Pinner

971 total citations
33 papers, 452 citations indexed

About

Kate Pinner is a scholar working on Experimental and Cognitive Psychology, Cognitive Neuroscience and Endocrine and Autonomic Systems. According to data from OpenAlex, Kate Pinner has authored 33 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Experimental and Cognitive Psychology, 27 papers in Cognitive Neuroscience and 8 papers in Endocrine and Autonomic Systems. Recurrent topics in Kate Pinner's work include Sleep and related disorders (31 papers), Sleep and Wakefulness Research (27 papers) and Circadian rhythm and melatonin (8 papers). Kate Pinner is often cited by papers focused on Sleep and related disorders (31 papers), Sleep and Wakefulness Research (27 papers) and Circadian rhythm and melatonin (8 papers). Kate Pinner collaborates with scholars based in United States, United Kingdom and Japan. Kate Pinner's co-authors include Margaret Moline, Carlos Perdomo, Gary Zammit, Jane Yardley, Gleb Filippov, Mikko Kärppä, Naoki Kubota, Yuichi Inoue, Kohei Ishikawa and Patricia Murphy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and SLEEP.

In The Last Decade

Kate Pinner

29 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kate Pinner United States 8 385 383 245 56 19 33 452
Philip Jochelson United States 7 203 0.5× 213 0.6× 117 0.5× 42 0.8× 14 0.7× 8 313
Dalma Seboek Kinter Switzerland 7 354 0.9× 348 0.9× 227 0.9× 45 0.8× 13 0.7× 20 408
Clemens Muehlan Switzerland 14 423 1.1× 391 1.0× 328 1.3× 41 0.7× 4 0.2× 22 476
Gianina Luca Switzerland 6 172 0.4× 185 0.5× 69 0.3× 36 0.6× 5 0.3× 10 270
Ibrahim Farr United Kingdom 7 173 0.4× 179 0.5× 82 0.3× 25 0.4× 19 1.0× 8 337
Tom Rico United States 7 189 0.5× 161 0.4× 104 0.4× 38 0.7× 8 306
C Vigder Israel 4 181 0.5× 191 0.5× 199 0.8× 22 0.4× 4 0.2× 7 282
Judith A. Jacoby United States 10 188 0.5× 202 0.5× 66 0.3× 24 0.4× 9 0.5× 10 310
Yuji Hashizume Japan 7 185 0.5× 118 0.3× 59 0.2× 85 1.5× 4 0.2× 14 244

Countries citing papers authored by Kate Pinner

Since Specialization
Citations

This map shows the geographic impact of Kate Pinner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Pinner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Pinner more than expected).

Fields of papers citing papers by Kate Pinner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate Pinner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Pinner. The network helps show where Kate Pinner may publish in the future.

Co-authorship network of co-authors of Kate Pinner

This figure shows the co-authorship network connecting the top 25 collaborators of Kate Pinner. A scholar is included among the top collaborators of Kate Pinner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate Pinner. Kate Pinner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drake, Christopher L., Jane Yardley, Kate Pinner, Margaret Moline, & Manoj Malhotra. (2025). Perception of Lemborexant Effectiveness as Assessed by the Patient Global Impression–Insomnia Questionnaire. Nature and Science of Sleep. Volume 17. 557–570. 1 indexed citations
2.
Côté, Kimberly A., et al.. (2025). Effect of Lemborexant on Daytime Functioning in Adults With Insomnia. The Primary Care Companion For CNS Disorders. 27(1). 1 indexed citations
3.
Krystal, Andrew D., Pierre Blier, Larry Culpepper, et al.. (2024). Efficacy and safety of lemborexant in subjects with insomnia disorder receiving medications for depression or anxiety symptoms. Neuropsychopharmacology Reports. 45(1). e12509–e12509. 2 indexed citations
4.
Arnold, Valerie, Sonia Ancoli‐Israel, Thien Thanh Dang‐Vu, et al.. (2024). Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder. Neurology and Therapy. 13(4). 1081–1098. 7 indexed citations
5.
6.
Yardley, Jane, Yuichi Inoue, Kate Pinner, et al.. (2023). Efficacy and safety of lemborexant in subjects previously treated with placebo for 6 months in a randomized phase 3 study. Sleep Medicine. 110. 111–119. 2 indexed citations
7.
Dash, Amitabh, Kate Pinner, Yuichi Inoue, et al.. (2022). Efficacy and safety of lemborexant over 12 months in Asian adults with insomnia disorder. SHILAP Revista de lepidopterología. 4. 100044–100044. 4 indexed citations
8.
Roth, Thomas, Russell Rosenberg, Charles M. Morin, et al.. (2022). Impact of lemborexant treatment on insomnia severity: analyses from a 12-month study of adults with insomnia disorder. Sleep Medicine. 90. 249–257. 14 indexed citations
9.
Rosenberg, Russell, Margaret Moline, Jane Yardley, et al.. (2022). Improvement in fatigue and sleep measures with the dual orexin receptor antagonist lemborexant in adults with insomnia disorder. Postgraduate Medicine. 134(3). 316–325. 9 indexed citations
10.
Yardley, Jane, Mikko Kärppä, Yuichi Inoue, et al.. (2021). Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: results from a phase 3 randomized clinical trial. Sleep Medicine. 80. 333–342. 53 indexed citations
11.
Mayleben, David, Russell Rosenberg, Kate Pinner, Ziad Hussein, & Margaret Moline. (2021). Assessment of morning sleep propensity with lemborexant in adults with insomnia disorder in a randomized, placebo-controlled crossover study. SLEEP Advances. 2(1). 3 indexed citations
12.
13.
Moline, Margaret, Jane Yardley, Kate Pinner, et al.. (2020). Efficacy and Safety of Lemborexant in Elderly Subjects with Insomnia Disorder: Pooled Analyses from SUNRISE-1 and SUNRISE-2 (1860). Neurology. 94(15_supplement). 2 indexed citations
14.
Drake, Chad E., et al.. (2019). Impact of lemborexant treatment on the patient global impression - insomnia scale. Sleep Medicine. 64. S96–S97. 1 indexed citations
15.
Moline, Margaret, Patricia Murphy, Kate Pinner, et al.. (2019). 0369 Effect of Lemborexant on Sleep Architecture in Older Adults with Insomnia Disorder. SLEEP. 42(Supplement_1). A150–A150. 3 indexed citations
16.
Yardley, Jane, Mikko Kärppä, Yuichi Inoue, et al.. (2019). Long-term effectiveness and safety of lemborexant in adults with insomnia disorder: 12-month results from sunrise-2. Sleep Medicine. 64. S263–S264. 3 indexed citations
17.
Roth, Tom, Russell Rosenberg, Patricia Murphy, et al.. (2019). 0371 Lemborexant Treatment for Insomnia in Phase 3: Impact on Disease Severity. SLEEP. 42(Supplement_1). A151–A151. 2 indexed citations
18.
Kärppä, Mikko, Margaret Moline, Jane Yardley, et al.. (2019). 0367 Lemborexant Treatment for Insomnia: 6-month Safety. SLEEP. 42(Supplement_1). A149–A150. 2 indexed citations
19.
Vermeeren, Annemiek, Stefan Jongen, Patricia Murphy, et al.. (2018). On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers. SLEEP. 42(4). 54 indexed citations
20.
Murphy, Patricia, Margaret Moline, David Mayleben, et al.. (2017). Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study. Journal of Clinical Sleep Medicine. 13(11). 1289–1299. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip Jochelson Breakdown of academic impact, for papers by Dalma Seboek Kinter Breakdown of academic impact, for papers by Clemens Muehlan Breakdown of academic impact, for papers by Gianina Luca Breakdown of academic impact, for papers by Ibrahim Farr Breakdown of academic impact, for papers by Tom Rico Breakdown of academic impact, for papers by C Vigder Breakdown of academic impact, for papers by Judith A. Jacoby Breakdown of academic impact, for papers by Yuji Hashizume
Rankless by CCL
2026